Literature DB >> 17990362

Poorly differentiated carcinoma of the rectum with aberrant immunophenotype: a case report.

A Giannopoulos1, I Papaconstantinou, P Alexandrou, A Petrou, A Papalambros, E Felekouras, E Papalambros.   

Abstract

We report a case of a poorly differentiated epithelial tumour of the rectum with a highly pleomorphic morphology and an aberrant immunophenotype, including the expression of epithelial markers, the focal parameter of neuroendocrine differentiation, and the unexpected detection of CD-117 overexpression. A 69-year-old man was admitted to our clinic complaining of rectal bleeding and weight loss. Colonoscopy showed an ulcerative bleeding mass located about 8 cm from the anal verge. Abdominal and pelvis CT scans demonstrated a large low-density lesion with extracanalicular growth from the middle rectum, with local lymph-node spread, and without tumour infiltration of other pelvic organs, or evidence of distant intra-abdominal spread. The patient underwent a low anterior resection for rectal cancer together with wide resection of lymph nodes. In immunohistochemical analysis, pankeratin and Epithelial Membrane Antigen (EMA) immunolabeling proved the epithelial nature of the tumor cells. Chromogranin A and Leukocyte Common Antigen (LCA) were negative, whereas CD-56 expression was scanty and Neuron Specific Enolase (NSA) was heavily and diffusely expressed. Ki67 immunoexpression was particularly increased. Interestingly, the intense c-kit immunoreactivity (100%) was a common feature. The above phenotypic and immunohistochemical profile was consistent with an anaplastic carcinoma of the large intestine, with focal neuroendocrine differentiation and diffuse immunoreactivity to c-kit protein. Given the resistance of this tumor to conventional chemotherapy and radiation, the incidence of the c-kit alteration may represent a novel approach to a gene-directed treatment using a c-kit inhibitor (STI571) similar to that which has been proposed in GISTs.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17990362      PMCID: PMC4205443          DOI: 10.3748/wjg.v13.i44.5951

Source DB:  PubMed          Journal:  World J Gastroenterol        ISSN: 1007-9327            Impact factor:   5.742


  20 in total

1.  Receptors in interstitial cells of Cajal: identification and possible physiological roles.

Authors:  M G Vannucchi
Journal:  Microsc Res Tech       Date:  1999-12-01       Impact factor: 2.769

2.  Coexpression of c-kit and stem cell factor in breast cancer results in enhanced sensitivity to members of the EGF family of growth factors.

Authors:  S J Hines; J S Litz; G W Krystal
Journal:  Breast Cancer Res Treat       Date:  1999-11       Impact factor: 4.872

3.  Evidence for a functional kit receptor in melanoma, breast, and lung carcinoma cells.

Authors:  R S DiPaola; W I Kuczynski; K Onodera; M Z Ratajczak; N Hijiya; J Moore; A M Gewirtz
Journal:  Cancer Gene Ther       Date:  1997 May-Jun       Impact factor: 5.987

Review 4.  Early signaling pathways activated by c-Kit in hematopoietic cells.

Authors:  D Linnekin
Journal:  Int J Biochem Cell Biol       Date:  1999-10       Impact factor: 5.085

5.  The effect of surgery and grade on outcome of gastrointestinal stromal tumors.

Authors:  J P Pierie; U Choudry; A Muzikansky; B Y Yeap; W W Souba; M J Ott
Journal:  Arch Surg       Date:  2001-04

6.  Stem cell factor suppresses apoptosis in neuroblastoma cell lines.

Authors:  F Timeus; N Crescenzio; P Valle; P Pistamiglio; M Piglione; E Garelli; E Ricotti; P Rocchi; P Strippoli; L Cordero di Montezemolo; E Madon; U Ramenghi; G Basso
Journal:  Exp Hematol       Date:  1997-11       Impact factor: 3.084

Review 7.  Gastrointestinal stromal tumors: current diagnosis, biologic behavior, and management.

Authors:  I Pidhorecky; R T Cheney; W G Kraybill; J F Gibbs
Journal:  Ann Surg Oncol       Date:  2000-10       Impact factor: 5.344

Review 8.  Diagnosis of gastrointestinal stromal tumors: A consensus approach.

Authors:  Christopher D M Fletcher; Jules J Berman; Christopher Corless; Fred Gorstein; Jerzy Lasota; B Jack Longley; Markku Miettinen; Timothy J O'Leary; Helen Remotti; Brian P Rubin; Barry Shmookler; Leslie H Sobin; Sharon W Weiss
Journal:  Hum Pathol       Date:  2002-05       Impact factor: 3.466

9.  Nonhematopoietic tumor cell lines express stem cell factor and display c-kit receptors.

Authors:  A M Turner; K M Zsebo; F Martin; F W Jacobsen; L G Bennett; V C Broudy
Journal:  Blood       Date:  1992-07-15       Impact factor: 22.113

10.  Expression of stem cell factor and its receptor by human neuroblastoma cells and tumors.

Authors:  D Beck; N Gross; C B Brognara; G Perruisseau
Journal:  Blood       Date:  1995-10-15       Impact factor: 22.113

View more
  2 in total

1.  Poorly Differentiated Neuroendocrine Carcinoma of the Sigmoid Colon-a Rare Differential Diagnosis of Malignant Colon Tumours.

Authors:  Ahmed Abdel Samie; Rui Sun; Afshin Fayyazi; Lorenz Theilmann
Journal:  J Gastrointest Cancer       Date:  2012-09

2.  SNAP-Tag Technology: A Promising Tool for Ex Vivo Immunophenotyping.

Authors:  Swati Choudhary; Stefan Barth; Rama S Verma
Journal:  Mol Diagn Ther       Date:  2017-06       Impact factor: 4.074

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.